K122288 is an FDA 510(k) clearance for the BRAINSWAY DEEP TMS SYSTEM. Classified as Transcranial Magnetic Stimulator (product code OBP), Class II - Special Controls.
Submitted by Brainsway , Ltd. (Kfar Saba, IL). The FDA issued a Cleared decision on January 7, 2013 after a review of 161 days - an extended review cycle.
This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5805 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.
View all Brainsway , Ltd. devices
NCT00927173
Completed
Interventional
Industry-sponsored
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
| Condition studied |
Major Depressive Disorder |
| Study design |
Parallel |
| Eligibility |
All sexes
· 22 Years+
|
| Principal investigator |
Yechiel Levkovitz, M.D |
| Sponsor |
Brainsway
(industry)
|
Started 2009-09-01
→
Primary completion 2012-03-01
→
Completed 2012-06-01
Secondary outcome
Response rate
Study completed - no results published.
This trial concluded in 2012 but has not posted
results to ClinicalTrials.gov. Completed studies without public results are common
in industry-sponsored device trials; the data may be referenced in the
510(k) Summary PDF or remain unpublished.
View full study on ClinicalTrials.gov